KennethJWarringtonMD

PubMed

• 21 citations
  Concurrent Takayasu Arteritis With Common Variable Immunodeficiency and Moyamoya Disease
  Nedaa Skeik, Kyle K. Rumery, Prabhu D. Udayakumar, B Crandall, Kenneth J. Warrington
  Annals of Vascular Surgery. 2013-02-01
• 122 citations
  A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility.
  F. David Carmona, Sarah L. Mackie, Jose Ezequiel Martin, John C. Taylor, Augusto Vaglio
  American Journal of Human Genetics. 2015-04-02
• 18 citations
  Effect of omega-3 fatty acids on systemic lupus erythematosus disease activity: A systematic review and meta-analysis.
  Alí Duarte-García, Elena Myasoedova, Paras Karmacharya, Mehmet Hocaoglu, M. Hassan Murad
  Autoimmunity Reviews. 2020-12-01

Journal Articles

• Body mass index and the risk of giant cell arteritis-results from a prospective study  
  Jakobsson K, Jacobsson L, Warrington K , Matteson EL, Liang K, Melander O, Turesson C, Rheumatology, 9/1/2014
• Cardiovascular risk and acute coronary syndrome in giant cell arteritis: A population based retrospective cohort study  
  Udayakumar PD, Chandran AK, Crowson CS, Warrington KJ , Matteson EL, Arthritis Care Res, 7/1/2014
• Vasculitis associated with rheumatoid arthritis: a case-control study  
  Makol A, Crowson CS, Wetter DA, Sokumbi O, Matteson EL, Warrington KJ, Rheumatology, 5/1/2014
• Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis  
  Kermani TA, Warrington KJ , Crowson CS, Ytterberg SR, Hunder GG, Gabriel SE, Matteson EL, Ann Rheum Dis, 12/1/2013
• Diagnostic features, treatment, and outcomes of Takayasu arteritis in a US cohort of 126 patients  
  Schmidt J, Kermani TA, Bacani AK, Crowson CS, Cooper LT, Matteson EL, Warrington KJ, Mayo Clin Proc, 8/1/2013
• Comment on: How common is inflammatory marker-negative disease in giant cell arteritis?  
  Kermani TA, Warrington KJ, Eye, 5/1/2013
• Biopsy findings in giant cell arteritis: relationship to baseline factors and corticosteroid treatment  
  Jakobsson K, Jacobsson L, Warrington K , Matteson EL, Turesson C, Scand J Rheumatol, 1/1/2013
• Vasculitis Clinical Research Consortium Distribution of arterial lesions in Takayasu's arteritis and giant cell arteritis  
  Grayson PC, Maksimowicz-McKinnon K, Clark TM, Tomasson G, Cuthbertson D, Carette S, Khalidi NA, Langford CA, Monach PA, Seo P, Warrington KJ , Ytterberg SR, Hoffman GS..., Ann Rheum Dis, 8/1/2012
• Pneumocystis jiroveci pneumonia in giant cell arteritis: A case series  
  Kermani TA, Ytterberg SR, Warrington KJ, Arthritis Care Res, 5/1/2011
• Malignancy risk in vasculitis  
  Kermani TA, Warrington KJ , Amin S, Ther Adv Musculoskelet Dis, 2/1/2011
• Incidence of herpes zoster in patients with giant cell arteritis: a population-based cohort study  
  Schafer VS, Kermani TA, Crowson CS, Hunder GG, Gabriel SE, Ytterberg SR, Matteson EL, Warrington KJ, Rheumatology, 11/1/2010
• Personalized medicine for the vasculitis patient: hope for the future?  
  Warrington KJ , Matteson EL, International Journal of Clinical Rheumatology, 4/1/2009
• Treatment of giant cell arteritis  
  Warrington KJ, Clinical & Surgical Journal of Ophthalmology, 1/1/2008
• Rheumatoid arthritis: emerging insights into the cause of rheumatoid arthritis  
  Warrington KJ , Weyand CM, Goronzy JJ, The Journal of Musculoskeletal Medicine, 10/1/2001
• Join now to see all

Books/Book Chapters

• Current therapy in vascular and endovascular surgery 
  Chapter: Giant cell arteritis 
  Kermani TA, Warrington KJEditors: Stanley JC; Veith FJ; Wakefield TW.Elsevier/Saunders, Philadelphia, PAEdition 5th,2014
• Color Atlas and Synopsis of Vascular Medicine 
  Chapter: Granulomatosis with polyangiitis (Wegener) 
  Kermani TA, Warrington KJEditors: Dean SM; Satiani B; Abraham WT.McGraw-Hill Education/Medical, New York, NY2014
• Color Atlas and Synopsis of Vascular Medicine 
  Chapter: Microscopic polyangiitis 
  Makol A, Warrington KJEditors: Dean SM; Satiani B; Abraham WT.McGraw-Hill Education/Medical, New York, NY2014
• Color Atlas and Synopsis of Vascular Medicine 
  Chapter: Churg-Strauss syndrome (eosinophilic granulomatosis with polyangiitis) 
  Makol A, Warrington KJEditors: Dean SM; Satiani B.McGraw-Hill Education/Medical, New York, NY2014
• Challenging Cases in Rheumatology and Diseases of the Immune System 
  Chapter: Vasculitis: Giant Cell Arteritis 
  Kermani TA, Warrington KJEditors: M. Mahmoudi.Springer2013
• Inflammatory diseases of blood vessels 
  Chapter: Vasculitis and relapsing polychondriti 
  Kermani TA, Warrington KJEditors: Hoffman GS; et al.Wiley-Blackwell2012
• Systemic Vasculitis. Imaging Features 
  Chapter: Polyarteritis Nodosa 
  Friese JL, Warrington KJ, Miller DV, Ytterberg SR, Fleming CJ, Stanson AWEditors: Hendaoui L, Stanson AW, Bouhaouala MH, Joffre F.Springer2011
• Rutherford's Vascular Surgery 
  Chapter: Vasculitis and Other Uncommon Arteriopathies 
  Warrington KJ , Cooper LTEditors: Cronenwett JL, Johnston W.ElsevierEdition 7th,2010
• Monograph for British Medical Journal Point of Care 
  Chapter: Giant cell arteritis 
  Warrington KJ , Matteson EL2007
• Mayo Clinic medical manual 
  Chapter: Connective tissue diseases 
  Warrington KJ , Ytterberg SREditors: Oliveira GHM, Nesbitt GC, Murphy JG.Mayo Clinic Scientific Press, Taylor & Francis Group, Boca Raton, FL2006
• Join now to see all

Abstracts/Posters

• Outcomes of Vascular Interventions in Takayasu's Arteritis: A Retrospective Cohort Study
  Labarca CH, Makol A, Crowson CS, Kermani TA, Matteson EL, Warrington KJ, Ann Rheum Dis, 1/1/2014
• Aortic dissection complicating Giant Cell Arteritis
  Makol A, Kebed DT, Bois JP, Connolly HM, Foley TA, Askew JA, Maleszewski JJ, Greason KL, Schaff HV, Warrington KJ , Anavekar NS, Ann Rheum Dis, 1/1/2014
• Aortic dissection and rupture in patients with giant cell arteritis a single center retrospective review of 195 consecutive patients
  Kebed DT, Bois J, Connolly H, Bowen J, Warrington K , Foley T, Askew JW, Maleszewski J, Greason K, Schaff H, Anavekar N, Circulation, 11/1/2013
• The stat1 signaling pathway in giant cell arteritis
  Hartmann B, Liao J, Weisman MH, Warrington KJ , Goronzy JJ, Weyand CM, Arthritis Rheum, 10/1/2013
• Infections requiring or acquired during hospitalizations in patients with giant cell arteritis - a population based retrospective cohort study
  Udayakumar PD, Chandran AK, Crowson CS, Warrington KJ , Matteson EL, Arthritis Rheum, 10/1/2013
• Cardiovascular risk at incidence of giant cell arteritis: a population based retrospective cohort study
  Udayakumar PD, Chandran AK, Crowson CS, Warrington KJ , Matteson EL, Arthritis Rheum, 10/1/2013
• Aortic dissection in giant cell arteritis: a population-based study of predictors
  Kermani T, Warrington K, Crowson C, Hunder G, Ytterberg S, Gabriel S, Matteson E, Presse Med, 4/1/2013
• Visual manifestations in giant cell arteritis: trend over five decades
  Singh AG, Crowson CS, Kermani TA, Weyand CM, Matteson EL, Warrington KJ, Arthritis Rheum, 10/1/2012
• Large vessel disease in giant cell arteritis: a population-based cohort study of incidence trends
  Warrington KJ , Kermani TA, Crowson CS, Ytterberg SR, Hunder GG, Gabriel SE, Matteson EL, Rheumatology, 2/1/2012
• Computed Tomodensitometric (CT) Angiogarphic Imaging Characteristics of Idiopathic Aortitis: A Case Control Study
  Chowdhary VR, Crowson CS, Warrington KJ , Vrtiska TJ, Ann Rheum Dis, 1/1/2012
• Diagnosis of gout using dual-energy computed tomography: an accuracy and diagnostic yield study
  Bongartz T, Glazebrook KN, Kavros SJ, Michet CJ, Merry SP, Murthy NS, Akkara Veetil BM, Davis JM III, Mason TG II, Warrington KJ , Manek NJ, Kermani TA, Hoganson DD, B..., Arthritis Rheum, 10/1/2011
• Increased mortality in giant cell arteritis with large vessel disease: a population-based cohort study
  Kermani TA, Warrington KJ , Crowson CS, Ytterberg SR, Hunder GG, Gabriel SE, Matteson EL, Arthritis Rheum, 10/1/2011
• Serum biomarkers in GCA
  Warrington KJ , Kermani TA, Crowson CS, Ytterberg SR, Matteson EL, Snyder MR, Clin Exp Immunol, 5/1/2011
• Distribution of thoracic large arterial lesions in TA compared to GCA
  Grayson PC, Tomasson G, Cuthbertson D, Carette S, Hoffman GS, Khalidi NA, Langford CA, McAlear CA, Monach PA, Seo P, Warrington KJ , Ytterberg SR, Merkel PA, Clin Exp Immunol, 5/1/2011
• Lower Body Mass Index Is Associated with an Increased Risk of Giant Cell Arteritis
  Jakobsson K, Jacobsson LT, Warrington KJ , Matteson EL, Liang KP, Melander O, Turesson C, Arthritis Rheumatism, 10/1/2010
• Risk of malignancy in patients with Giant Cell Arteritis: A population-based study
  Kermani TA, Crowson CS, Hunder GG, Gabriel SE, Ytterberg SR, Matteson EL, Warrington KJ, Malta Medical Journal, 11/1/2009
• Clinical predictors of biopsy proven giant cell arteritis
  Karban MJ, Rieck KL, Abu Hilal MA, Thomsen KM, Harmsen WS, Warrington KJ, Journal of Oral and Maxillofacial Surgery, 9/1/2009
• Lower extremity involvement in giant cell arteritis: a case series
  Kermani T, Matteson EL, Hunder GG, Warrington KJ, Arthritis Rheum, 12/1/2008
• Increased risk of peripheral arterial disease in polymyalgia rheumatica: A population-based cohort study
  Jarpa E, Warrington KJ , Crowson CS, Cooper LT, Hunder GG, Matteson EL, Gabriel SE, Arthritis Rheum, 12/1/2007
• Anti-fibrogenic T cells in scleroderma
  Warrington KJ , Carbone LD, Nair U, Kang AH, Postlethwaite AE, Southern Society for Clinical Investigation Meeting, 2/1/2005
• Type I collagen-specific memory CD4 T cells in scleroderma
  Warrington KJ , Carbone LD, Nair U, Postlethwaite AE, Amgen Rheumatology Young Investigator Forum, 2/1/2004
• Autoimmune lymphocyte response at sites remote to myocardial infarction
  Gideon PA, Warrington KJ , Lu L, Sun Y, Weber KT, Circulation, 1/1/2003
• Regulation of CD28 in senescent T cells
  Vallejo AN, Bryl E, Warrington KJ , Weyand CM, Goronzy JJ, 2nd International Conference on Giant Cell Arteritis and Polymyalgia Rheumatica, Meeting on GCA-PMR, 8/1/2002
• Ontogenesis of CD28null T cells in the aging immune system
  Vallejo AN, Bryl E, Warrington KJ , Lewis DE, Merced-Sauvage M, Weyand CM, Goronzy JJ, Conference on Immunology & Aging, 4/1/2002
• IL-12 mediated activation of cytotoxic CD4 T cells in acute coronary syndromes
  Nakajima T, Abbas AE, Schultz S, Warrington KJ, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM, J Am Coll Cardiol, 3/1/2002
• Join now to see all

Lectures

• Current advances in the diagnostic imaging for vasculitis. CAT scan, MRI, PET? Which to choose? 
  Santa Monica, CA - 10/1/2014
• My doctor says my vasculitis is in “remission”; so why do I still feel unwell? The current state of damage and disease activity assessment in vasculitis. Strategies to... 
  Santa Monica, CA - 10/1/2014
• Polymyalgia Rheumatica and Giant Cell Arteritis 
  Norwalk, CT - 1/1/2014
• Giant Cell Arteritis 
  Fargo, ND - 10/1/2013
• Vasculitis Concurrent Abstract Session 
  San Diego, CA - 10/1/2013
• Giant Cell Arteritis - Large Vessel Vasculitis 
  San Diego, CA - 10/1/2013
• Conventional Immunosuppressive Agents in the Treatment of Giant Cell Arteritis and Takayasu Arteritis 
  Cleveland, OH - 5/1/2013
• Large vessel disease in Giant Cell Arteritis: A population-based cohort study of incidence trends 
  Madrid, Spain - 1/1/2012
• Refractory Rheumatoid Pericarditis 
  Chicago, IL - 11/1/2011
• Pathogenesis of Large Vessel Vasculitis 
  Santiago, Chile - 4/1/2011
• Polymyalgia Rheumatica and Giant Cell Arteritis: Update on diagnosis and Treatment 
  Santiago, Chile - 4/1/2011
• Takayasu Arteritis: Update on diagnosis and treatment 
  Santiago, Chile - 4/1/2011
• Extracranial Giant Cell Arteritis 
  Santiago, Chile - 4/1/2011
• Pneumocystis Jirovecii Pneumonia in patients with Giant Cell Arteritis: A review of clinical features and outcomes 
  Rome, Italy - 6/1/2010
• What's New in Vasculitis 
  St. Paul, MN - 11/1/2009
• Risk of Malignancy in patients with Giant Cell Arteritis: A population-based study 
  Malta - 11/1/2009
• Update on Giant Cell Arteritis 
  Santiago, Chile - 5/1/2008
• Aortitis 
  Washington, DC - 8/1/2007
• Challenging GCA cases 
  Washington, DC - 8/1/2007
• Giant Cell Arteritis – The Mayo Clinic Experience 
  Freiburg, Germany - 6/1/2007
• The Coxib Controversy – To Use or Not To Use 
  Memphis, TN - 3/1/2006
• Lymphocyte activation and upregulation of anti-fibrotic cytokines by pamidronate treatment of patients with limited or diffuse scleroderma 
  San Diego, CA - 11/1/2005
• Characterization of the Immune Response to Collagen in Scleroderma 
  Atlanta, GA - 10/1/2004
• Rheumatoid Arthritis is an idependant risk factor for accelerated coronary artery disease 
  San Francisco, CA - 11/1/2001
• Join now to see all